Fresh analysis suggests that patients who discontinue popular GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who stop traditional diet and exercise programs.
Findings released in a leading medical journal shows that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing these drugs should be aware of the risk of fast weight regain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment mass in about 18 months.
Analyzing Therapies
The study, which reviewed 37 of studies involving thousands of patients, contrasted the effects of the injectable medications with other pills.
The team emphasize that individuals who lose weight through dieting typically have a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Doctors propose the way of the jabs accounts for the accelerated regain.
GLP-1 drugs copy a natural hormone called GLP-1, which controls hunger.
"Artificially providing the hormone levels several times higher than normal could lead to the system to produce less of its endogenous hormone, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement means hunger is uncontrolled, making overeating much more probable."
A Lifelong Issue?
Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians argue that, considering the significant potential of relapse, the therapy might need to be ongoing.
This perspective is supported by pharmaceutical companies, who state that the results "emphasize the long-term character of excess weight," similar to managing diseases like diabetes.
User Experiences
Individuals who have come off the medication explain a powerful return of cravings.
"I experienced a switch that goes on and you're instantly ravenous," recalled one woman.
The struggle is worsened if users have not established lasting dietary or behavioural modifications during treatment.
Growing Interest
Recent estimates show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is more common among females compared to males.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, experts emphasize that while the jabs are effective agents for weight loss, they are not a standalone solution and maintained weight loss likely depends on combined behavioural management.